| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Aug 2025 | 5 Aug 2025 |
| Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2025 and related matters | ||
| Board Meeting | 16 Jul 2025 | 16 Jul 2025 |
| Allotment of 91,86,490 Equity Shares of the Company on preferential basis upon conversion 91,86,490 fully paid warrants | ||
| Board Meeting | 3 Jul 2025 | 3 Jul 2025 |
| The Board of Directors of the Company in its meeting held today i.e. 03rd July, 2025 has allotted convertible Warrants to 23 allottees. | ||
| Board Meeting | 13 May 2025 | 6 May 2025 |
| Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve Annual Financial Results and Fund Raising Outcome of the Meeting of Board of Directors of Suven Life Sciences Limited held on Tuesday, May 13, 2025 (As Per BSE Announcement dated on 13.05.2025) | ||
| Board Meeting | 24 Jan 2025 | 16 Jan 2025 |
| SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31 2024 and related matters Unaudited standalone & consolidated financial results for quarter ended December 31, 2024 (As Per BSE Announcement dated on 24.01.2025) | ||
| Board Meeting | 29 Oct 2024 | 21 Oct 2024 |
| SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve consider and approve among other things inter alia and take on record: Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30 2024 Financial results for quarter & half-year ended 30/09/2024 (As Per BSE Announcement dated on 29.10.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.